CLINICAL TRIALS PROFILE FOR CLOMIPHENE CITRATE

All Clinical Trials for CLOMIPHENE CITRATE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00005104 ↗	Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome	Completed	University of Virginia	N/A	2000-01-01	OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.
NCT00005104 ↗	Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome	Completed	National Center for Research Resources (NCRR)	N/A	2000-01-01	OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.
NCT00005654 ↗	Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome	Completed	University of Virginia	N/A	2000-01-01	OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene or spontaneous ovulation in obese women with polycystic ovary syndrome.
NCT00005654 ↗	Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome	Completed	National Center for Research Resources (NCRR)	N/A	2000-01-01	OBJECTIVES: I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene or spontaneous ovulation in obese women with polycystic ovary syndrome.
NCT00068861 ↗	Treatment of Infertility in Women With Polycystic Ovary Syndrome	Completed	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 3	2002-11-01	Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women. The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair, acne, and infertility. This study will test a combination of medications in women with PCOS to determine which works best to overcome infertility.
NCT00213148 ↗	Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction	Completed	EMD Serono	Phase 2	2005-03-10	The purpose of this study is to investigate and compare the safety and efficacy of various doses of the aromatase inhibitor (anastrozole) versus clomiphene citrate in stimulating follicular growth and ovulation in infertile women with ovulatory dysfunction.

Clinical Trial Conditions for CLOMIPHENE CITRATE

Condition Name

Condition Name for CLOMIPHENE CITRATE
Intervention	Trials
Infertility	59
Polycystic Ovary Syndrome	50
Anovulation	14
Polycystic Ovarian Syndrome	11

Condition MeSH

Condition MeSH for CLOMIPHENE CITRATE
Intervention	Trials
Infertility	84
Polycystic Ovary Syndrome	80
Syndrome	48
Anovulation	19

Clinical Trial Locations for CLOMIPHENE CITRATE

Trials by Country

Trials by Country for CLOMIPHENE CITRATE
Location	Trials
United States	100
Egypt	55
Italy	10
China	9
Brazil	5

Trials by US State

Trials by US State for CLOMIPHENE CITRATE
Location	Trials
New York	7
Texas	7
Michigan	6
California	6
Alabama	5

Clinical Trial Progress for CLOMIPHENE CITRATE

Clinical Trial Phase

Clinical Trial Phase for CLOMIPHENE CITRATE
Clinical Trial Phase	Trials
Phase 4	50
Phase 3	27
Phase 2/Phase 3	10

Clinical Trial Status

Clinical Trial Status for CLOMIPHENE CITRATE
Clinical Trial Phase	Trials
Completed	95
Unknown status	32
Not yet recruiting	16

Clinical Trial Sponsors for CLOMIPHENE CITRATE

Sponsor Name

Sponsor Name for CLOMIPHENE CITRATE
Sponsor	Trials
Cairo University	15
Ain Shams University	12
Assiut University	10

Sponsor Type

Sponsor Type for CLOMIPHENE CITRATE
Sponsor	Trials
Other	243
Industry	17
NIH	8